Keros Therapeutics, Inc.
Pharmaceutical company · Lexington, Massachusetts, United States · Nasdaq: KROS
Keros Therapeutics, Inc. is a pharmaceutical company headquartered in Lexington, Massachusetts, United States. Its earliest recorded incorporation is in 2015. Its shares trade on Nasdaq under the ticker KROS. It has reported private securities offerings to the US SEC, most recently $11 million sold in a notice filed in 2018.
Keros Therapeutics at a glance
What does Keros Therapeutics do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $11.5 million sold (2018).
Frequently asked questions about Keros Therapeutics
Where is Keros Therapeutics headquartered?
Keros Therapeutics, Inc. is headquartered in Lexington, Massachusetts, United States.
What does Keros Therapeutics do?
Keros Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Keros Therapeutics a public company?
Yes. Keros Therapeutics, Inc. trades on Nasdaq under the ticker KROS.
When was Keros Therapeutics founded?
The earliest incorporation on record for Keros Therapeutics, Inc. is in 2015, according to public company registers.
Similar companies
- Dicerna Pharmaceuticals IncLexington, Massachusetts, United States
- Aldeyra Therapeutics, Inc.Lexington, Massachusetts, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.